REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy	Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, estrogen-receptor positive breast cancer, neoplasm, skin disorder	Active, not recruiting	Phase 2	2026-01-28		NCT01984138

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Polly A. Niravath, MD	2

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Houston Methodist Cancer Center	Houston	United States	18

Clinical trials